We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of CTIC yet.

CTIC Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q3 2023, worth a combined $0 — down 100% from $474K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CTIC and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was UBS AM, exiting entirely with an estimated $389K sold.

  • 0 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q3 2023, down from 2 in Q2 2023.
  • Funds reported $0 of CTI BioPharma Corp. (DE) Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q3 2023 and 2 closed out, a net change of -2 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q3 2023 was UBS AM, an estimated $389K sold.

Based on aggregated 13F filings for Q3 2023.